Advances in genetic and molecular profiling can enable more personalized treatment approaches, improving outcomes and ...

The terms tumor and cancer can refer to different types of lumps and bumps. But the terms are often confused and misused—by ...

Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will ...

TAIPEI (Taiwan News) — Linkou Chang Gung Memorial Hospital used robotic arms to treat a 46-year-old woman surnamed Huang (黃), ...

NanOlogy, LLC, a private clinical-stage oncology company, is pleased to announce its drug development program aimed at transformin ...

A tool that incorporates five predictors helps accurately identify patients with dermatomyositis who have an increased likelihood of concomitant cancer and can be used to help with early detection.

The JS001sc-002-III-NSCLC Study is a multi-center, open-label, randomized Phase 3 clinical study led by the principal investigator Professor Lin WU from Hunan Cancer Hospital. JS001sc-002-III-NSCLC is ...

National Cancer Institute/Unsplash The terms tumour and cancer can refer to different types of lumps and bumps. But the terms ...

Jennifer Capasso has endured a lot of hate while undergoing care at one of the world's best cancer hospitals.

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

BioNTech stock is a "Strong Buy", driven by positive phase 3 data for gotistobart in 2nd-line squamous NSCLC patients. Read ...

Abstracts presented include 3 studies involving 263 patients, adding to a growing body of evidence across diverse patient populations supporting broader adoption of ProSense (R) ...